Screener
NovoCure NVCR Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: NovoCure’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001645113-26-000062
| Line item | June 30,2026 | December 31, 2025 |
|---|---|---|
| CURRENT LIABILITIES: | ||
| Trade payables | 130,729 | 122,231 |
| Other payables, lease liabilities and accrued expenses | 89,981 | 100,997 |
| Total current liabilities | 220,710 | 223,228 |
| LONG-TERM LIABILITIES: | ||
| Senior secured credit facility, net | 195,891 | 195,047 |
| Long-term leases | 37,529 | 41,647 |
| Employee benefit liabilities | 2,969 | 3,938 |
Item 1. Financial Statements
FAQ
- What is NovoCure's total current liabilities?
- NovoCure (NVCR) reported total current liabilities of $220.71M in Q2 2026.
- How has NovoCure's total current liabilities changed year-over-year?
- NovoCure's total current liabilities decreased by 70.6% year-over-year, from $749.63M to $220.71M.
- What is the long-term trend for NovoCure's total current liabilities?
- Over 5 years (2020 to 2025), NovoCure's total current liabilities has grown at a 14.5% compound annual growth rate (CAGR), from $113.61M to $223.23M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about NovoCure's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude